Letter to our Customers

Dear Customers and Partners,

NanoString begins a promising new era in its history this week. We are delighted to share news that NanoString is now a part of Bruker Corporation. 

From R & D to sales, operations to marketing, NanoString team members are excited to join Bruker. Our enthusiasm comes from Bruker’s track record of innovation and distinctive philosophy of disciplined entrepreneurism, a business approach that supports NanoString’s ambitious R & D roadmap. Bruker is also a life science leader globally. With $2.9 billion in revenue in 2023 and nearly 9,000 employees worldwide, Bruker has an impressive history of serving the scientific community with reliable, high-performance analytical, life science and diagnostic solutions. Combined with NanoString’s entrepreneurial record of developing innovations in genomic analysis and pioneering spatial biology, our organizations are well-aligned and ready to deploy our capabilities for the benefit of science and in service to customers.  

The process of integrating NanoString into Bruker’s community of companies is well underway, and our goal is to ensure you experience no disruption during the transition. NanoString continues to operate under business-as-usual circumstances. There are no changes to how you order, receive, and pay for your products. You will continue working with the same sales, service, and science personnel you worked with before the integration. Our contracts, collaborations, scientific projects, and distribution partnerships will remain intact and unchanged. You can find an FAQ document about the integration on our website. Our sales representatives are eager to connect with you and share more information. 

For 20 years NanoString has served the scientific community by providing pioneering innovations for spatial transcriptomics, proteomics, and gene expression analysis. We have celebrated the breakthrough scientific discoveries you have made with our platforms and the thousands of peer-reviewed studies you published to amplify the impact of your research. As a part of Bruker, we are confident our history of developing breakthrough technologies and supporting leading-edge science will continue to prosper.  

NanoString’s future is stronger than ever, and so is our commitment to our customers, accelerating their progress in the post-genomic era, and leading the revolution in spatial biology research. 

Best Regards,

Todd Garland
Chief Scientific Officer, NanoString Technologies, A Bruker Company